Lasers safely target areas of limited psoriatic lesions
Washington - Lasers can offer a safe and effective alternative for the treatment of chronic, stable plaque psoriasis in patients whose disease is mild-to-moderate in severity and involves 10 to 20 percent of the body surface area, said Christine C. Dierickx, M.D., at the annual meeting of the American Academy of Dermatology here. Dr. Dierickx, director, Boom Laser Clinic, Boom, Belgium, and visiting scientist, Harvard Medical School, Boston, described the roles of lesion-directed, high intensity UVB phototherapy using various lasers and light sources as well as pulsed dye laser treatment that clears psoriatic plaques by targeting the microvasculature.
The FDA approved therapies for melanoma, dermatomyositis, superficial basal cell carcinoma, and adolescent alopecia areata, while TYK2 inhibitors and rare disease filings advanced toward 2027 decisions.
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
The FDA approval, based on 36-week data from the phase 3 BRAVE-AA-PEDS trial, extends baricitinib access to patients as young as 12 years old with severe alopecia areata.